Acquiring Company
Danaher
Acquired Company
Abcam plc
Description
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Danaher’) will acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).
Other recent acquisitions in Financial Services and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Airlife Completes Acquisition Of Avanos Medical’S Respiratory Health Business (October 2, 2023)
- Danaher To Acquire Abcam (August 28, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Abbott Completes Acquisition Of Bigfoot Biomedical (September 22, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
Who to call at Danaher, and when
When Danaher changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Danaher raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Danaher, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Danaher. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Danaher makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Abcam plc?
Abcam plc was acquired by Danaher, based in Washington. The deal was reported on August 28, 2023. Danaher is publicly traded (DHR) and operates in Manufacturing.
When did Danaher acquire Abcam plc?
Danaher's acquisition of Abcam plc was reported on August 28, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Abcam plc do?
As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission faster. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.